Ashurst advised Kreissparkasse Biberach and Sparkasse Freiburg-Nördlicher Breisgau as lenders on the financing of the acquisition of mymediset by Afinum. The parties have agreed not to disclose the terms and conditions of the financing.
Mymediset with headquarters in Freiburg / Germany is a world-leading technology provider for SAP-integrated medical device management. The company has expanded internationally over recent years serving a customer base in now over 40 countries. Afinum acquires a majority stake in mymediset joining forces as a growth partner with founder and CEO Michael Knauer to drive and execute the company’s next growth phase.
Afinum is an independent private equity firm with offices in Munich, Zurich and Hong Kong. It specialises in taking stakes in successful mid-market companies in the German-speaking countries.
The Ashurst team was led by partner Dr Matthias Weissinger. He was assisted by senior associate Franziska Sauer, associate Lorenz Schwojer and senior transaction lawyer Ena Selimbegovic (all Global Loans).
Ashurst’s German banking and finance practice advises both banks and alternative lenders, private equity investors and companies on domestic and cross-border acquisition, real estate, asset and infrastructure / project finance as well as on financial restructuring and corporate lending.
